Copyright
©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 525-534
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.525
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.525
Figure 1 Hepatitis C virus screening flowchart for oncologic patients eligible for chemotherapy.
HCV: Hepatitis C virus; DAA: Direct aging antiviral.
- Citation: Spera AM. Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review. World J Hepatol 2022; 14(3): 525-534
- URL: https://www.wjgnet.com/1948-5182/full/v14/i3/525.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i3.525